Affimed Nv Stock Investor Sentiment

AFMD Stock  USD 1.03  0.02  1.90%   
About 64% of Affimed NV's investor base is looking to short. The analysis of the overall investor sentiment regarding Affimed NV suggests that many traders are alarmed. The current market sentiment, together with Affimed NV's historical and current headlines, can help investors time the market. In addition, many technical investors use Affimed NV stock news signals to limit their universe of possible portfolio assets.
  

Affimed NV Sentiment by Major News Outlets

Investor sentiment, mood or attitude towards Affimed NV can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
over three weeks ago at thelincolnianonline.com         
Affimed Short Interest Down 12.3 percent in January
news
over a month ago at thelincolnianonline.com         
Affimed Stock Price Passes Below 50-Day Moving Average Time to Sell?
news
over a month ago at thelincolnianonline.com         
Short Interest in Affimed Rises By 38.5
news
over two months ago at thelincolnianonline.com         
HC Wainwright Issues Optimistic Outlook for Affimed Earnings
news
over two months ago at thelincolnianonline.com         
Brokerages Set Affimed Price Target at 13.50
news
over two months ago at businesswire.com         
ALKemist Bio Appoints Adi Hoess to Board of Directors
businesswire News
over two months ago at finance.yahoo.com         
Affimed Reports Positive Clinical Update on AFM24Atezolizumab Combination Therapy in Non-Small Cell ...
Yahoo News
over two months ago at gurufocus.com         
Affimed Reports Positive Clinical Update on AFM24Atezolizumab Combination Therapy in Non-Small ...
Gurufocus Stories at Macroaxis
over two months ago at gurufocus.com         
Affimed Shares Fall 32 percent on Clinical Update
Gurufocus Stories at Macroaxis
over two months ago at thelincolnianonline.com         
Affimed Price Target Cut to 15.00 by Analysts at Wells Fargo Company
news
over two months ago at thelincolnianonline.com         
HC Wainwright Reaffirms Buy Rating for Affimed
news
over two months ago at gurufocus.com         
Affimed to Host Investor Conference Call Highlighting Clinical Data from AFM24 in Combination ...
Gurufocus Stories at Macroaxis
over two months ago at gurufocus.com         
Affimed Reports Promising Phase 1 Efficacy and Safety Data for AFM28 in RelapsedRefractory ...
Gurufocus Stories at Macroaxis
over two months ago at globenewswire.com         
Affimed Reports Promising Phase 1 Efficacy and Safety Data for AFM28 in RelapsedRefractory Acute Mye...
Macroaxis News: globenewswire.com
over two months ago at seekingalpha.com         
Affimed reports data from mid-stage study of its lymphoma treatment
seekingalpha News
Far too much social signal, news, headlines, and media speculation about Affimed NV that are available to investors today. That information is available publicly through Affimed media outlets and privately through word of mouth or via Affimed internal channels. However, regardless of the origin, that massive amount of Affimed data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Affimed NV news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Affimed NV relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Affimed NV's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Affimed NV alpha.

Affimed NV Performance against Dow Jones

 Price Growth (%)  
       Timeline  
1
Affimed Announces Acimtamig and AlloNK Combination Granted Regenerative Medicine Advanced Therapy Designation by the U.S. Food and Drug Administration
12/05/2024
2
Affimed to Host Investor Conference Call Highlighting Clinical Data from AFM24 in Combination ...
12/09/2024
3
Affimed Price Target Cut to 15.00 by Analysts at Wells Fargo Company
12/13/2024
4
Affimed Reports Positive Clinical Update on AFM24Atezolizumab Combination Therapy in Non-Small Cell Lung Cancer
12/17/2024

Complementary Tools for Affimed Stock analysis

When running Affimed NV's price analysis, check to measure Affimed NV's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Affimed NV is operating at the current time. Most of Affimed NV's value examination focuses on studying past and present price action to predict the probability of Affimed NV's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Affimed NV's price. Additionally, you may evaluate how the addition of Affimed NV to your portfolios can decrease your overall portfolio volatility.
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency